The sticking point is how to charge for the in-depth clinical assessment that pharmacists must perform to determine whether Paxlovid can be safely prescribed.
The FDA significantly expanded the role of pharmacists in this pandemic by authorizing pharmacists under limited conditions to prescribe Paxlovid to treat mild...